The Confidence in Hereditary Cancer Discussion Series for Primary Care Providers was developed through a collaboration between the National Association of Chronic Disease Directors (NACDD) and the Family Medicine Education Consortium (FMEC), with funding from the Centers for Disease Control and Prevention.
About this series
This series is designed to improve family medicine healthcare providers’ skills and confidence in identifying and managing patients who may have a higher risk of hereditary breast cancer (HBC) due to genetic factors . Each module explores a vital aspect of identifying and managing HBC. Of particular interest is the use of narrative medicine, a powerful tool for engaging patients in discussions about HBC risk. Other topics include setting up the primary care office for HBC screening and referral, working with genetic counselors, and addressing patients’ concerns about insurance, disclosure, and communicating with family. We recommend viewing the modules in the order below, but it is not a requirement.
FMEC has also cataloged CME modules other organizations offer to accompany this series. This list is available below.
Watch our introduction video:
Confidence in Hereditary Cancer Discussion for Primary Care Providers Modules
Narrative Medicine Background and Use in Family Medicine
Narrative Medicine as a Tool to Support Patients with Hereditary Cancer Risk
Setting up the Family Practice for Hereditary Breast Cancer Risk Assessment, Testing, and Counseling, Part A
Setting up the Family Practice for Hereditary Breast Cancer Risk Assessment, Testing, and Counseling, Part B
Working with Genetic Counselors
Supporting Patients’ Common Questions and Concerns, Part A - Educational Resources for Talking with Families After Hereditary Cancer Screening
Supporting Patients’ Common Questions and Concerns, Part B - Common Questions about Insurance, Privacy, and Disclosure
CME Information The AAFP has reviewed Confidence in Hereditary Cancer Discussion for Primary Care Providers and deemed it acceptable for AAFP credit. Term of approval is from 07/01/2024 to 06/30/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Modules have been approved for 0.25 Self-Study AAFP Prescribed Credits. More information available at: https://www.aafp.org/credit-reporting/cmecenter/details?activityId=100520
Earning and Claiming Your Credit Once you have completed viewing a module, you will be directed to a link to complete the module evaluation to receive your Certificate of Participation. To self-report CME credit, visit the AAFP CME Reporter at www.aafp.org/credit-reporting/reporting/claim-credit
Confidence in Hereditary Cancer Discussion for Primary Care Providers Module Overviews
Module Name
AAFP Credits
Narrative Medicine Background and Use in Family Medicine
This module reviews the definition, history and core concepts of narrative medicine and helps physicians understand how narrative medicine can improve their practice, through improved physician-patient communication, empathy, and patient education.
Learning Objectives. By the end of this module, learners will be able to:
Describe the history and foundational concepts of narrative medicine.
Identify strategies to utilize narrative medicine in patient care and resources for patient education and empowerment.
Speaker: Philip G. Day, PhD, Associate Director of Education and an Assistant Professor of Family Medicine at the University of Massachusetts Chan Medical School
0.25 Prescribed credits
Narrative Medicine as a Tool to Support Patients with Hereditary Cancer Risk
This module demonstrates how exploring a diverse range of patients’ hereditary cancer journeys and learning from other physicians' experiences can change physician perspectives and improve patient care.
Learning Objectives. By the end of this module, learners will be able to:
Describe the benefits to both providers and patients of using narrative medicine and stories.
Find stories and videos that help them as healthcare providers feel confident in helping patients and avoid burnout.
Find stories and videos that help patients understand their cancer risk, find support, and take appropriate steps to help stay healthy.
Speaker: Maya Bass, MD MA FAAFP, Assistant Professor and Program Director, Department of Family Medicine, Cooper University
0.25 Prescribed credits
Setting up the Family Practice for Hereditary Breast Cancer Risk Assessment, Testing and Counseling, Part A
This two-part module addresses setting up the family practice office to assess and manage patients who may have a higher risk of hereditary cancer due to genetic factors. It covers risk assessment tools, practice protocols, finding and working with genetic counseling and testing, and helping providers and patients understand genetic test results.
Learning Objectives. By the end of this module, learners will be able to
Overcome barriers to the risk assessment and genetic testing referral for patients at risk of hereditary cancer in their practice.
Proceed with developing practice protocols, training, and other resources to make risk assessment and patient referrals routine.
Speaker: Susanna Evans, MD, Associate Professor and Hamot Endowed Chair, Department of Family, Community & Preventive Medicine, Drexel University College of Medicine.
0.25 Prescribed credits
Setting up the Family Practice for Hereditary Breast Cancer Risk Assessment, Testing and Counseling, Part B
This two-part module addresses setting up the family practice office to assess and manage patients who may have a higher risk of hereditary cancer due to genetic factors. It covers risk assessment tools, practice protocols, finding and working with genetic counseling and testing, and helping providers and patients understand genetic test results.
Learning Objectives. By the end of this module, learners will be able to
Identify genetic testing and counseling resources in their community;
Access resources that help them and their patients better understand genetic testing results.
Speaker: Susanna Evans, MD, Associate Professor and Hamot Endowed Chair, Department of Family, Community & Preventive Medicine, Drexel University College of Medicine.
0.25 Prescribed credits
Working with Genetic Counselors
This module helps primary care providers understand how genetic counselors are an important resource for patients who are considering genetic testing for hereditary cancers and other conditions and will address barriers and strategies to referring patients to genetic counselors.
Learning Objectives. By the end of this module, learners will be able to:
Describe the services that genetic counselors provide to patients considering or undergoing genetic testing
Overcome barriers that prevent primary care providers from using genetic counselors
Find genetic counseling services that can be accessed virtually or in-person for their patients
Speaker: Uchenna Emeche, MD, Associate Medical Director, Medstar Franklin Square Family Health Center
0.25 Prescribed credits
Supporting Patients’ Common Questions and Concerns, Part A - Educational Resources for Talking with Families After Hereditary Cancer Screening
The process of risk assessment, screening and testing for hereditary cancers can raise complex questions about insurance coverage, privacy, discrimination, and telling family members for patients. This module helps primary care providers understand some of the common questions that patients may have and how to help them.
Learning Objectives. By the end of this module, learners will be able to:
Listen compassionately to patients’ questions and concerns;
Provide basic guidance to patients who have concerns about insurance coverage, privacy, and discrimination during hereditary cancer screening and testing.
Speaker: Tracey Conti, MD, Chair, Department of Family Medicine, UPMC and University of Pittsburgh
0.25 Prescribed credits
Supporting Patients’ Common Questions and Concerns, Part B - Common Questions about Insurance, Privacy, and Disclosure
This module focuses on skills and resources physicians and their healthcare teams can use to support patients who have discovered they may carry a harmful gene in sharing information with their relatives and loved ones.
Learning Objectives. By the end of this module, learners will be able to:
Confidently and proactively promote the discussion of hereditary breast cancer risk between patients and their families;
Direct patients to resources to help them prepare for discussions with family members about hereditary cancer risk.
Speaker: Sarah Inés Ramírez, MD, Assistant Professor, Department of Family and Community Medicine, Penn State Cancer Institute
The American College of Osteopathic Family Physicians (ACOFP)
Funding NACDD’s Helping Families Communicate About Hereditary Breast or Ovarian Cancer project was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $450,000, with 100 percent funded by CDC/HHS.
Planners, Writers, and Reviewers Maya Bass, MD MA FAAFP, Assistant Professor and Program Director, Department of Family Medicine, Cooper University Tracey Conti, MD, Chair, Department of Family Medicine, UPMC and University of Pittsburgh Philip G. Day, PhD, Associate Director of Education and an Assistant Professor of Family Medicine at the University of Massachusetts Chan Medical School Uchenna Emeche, MD, Associate Medical Director, Medstar Franklin Square Family Health Center Susanna Evans, MD, Associate Professor and Hamot Endowed Chair, Department of Family, Community & Preventive Medicine, Drexel University College of Medicine. Sarah Inés Ramírez, MD, Assistant Professor, Department of Family and Community Medicine, Penn State Cancer Institute
Disclosure Statement The activity director, co-activity director, planning committee, writers, and reviewers involved in the Confidence in Hereditary Cancer Discussion for Primary Care Providers CME Series have no financial relationships with any companies that could be perceived as a conflict of interest. Furthermore, the modules within this series do not include any non-approved or investigational use of products or device.